Article | August 27, 2021

Avoiding The Risk Of A Non-Transparent Clinical Supply Solution

Source: AmerisourceBergen World Courier

One of the top challenges and a major cause of delays in sourcing comparators and co-therapies, as reported by participants in the Tufts Center for the Study of Drug Development12, is associated with obtaining required documentation – which includes equivalency documentation, certificates of conformity, certificates of analysis, and Bovine Spongiform Encephalopathy/Transmitting Animal Spongiform Encephalopathy (BSE/TSE) statements – from the manufacturer, along with temperature excursion and stability data.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Supply Leader? Subscribe today.

Subscribe to Clinical Supply Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Supply Leader